Dafna Capital Trims IShares ETF: Biotech Portfolio Moves
A major move by a prominent asset manager reveals how large portfolios tweak biotech bets. Learn what the trim means ...
Comparing effectiveness shows zero based budgeting frequently improves accuracy and alignment with goals versus traditional approaches.
19,639 articlesA major move by a prominent asset manager reveals how large portfolios tweak biotech bets. Learn what the trim means ...
When a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
The Stanford board sold HeartFlow shares for about $8.5 million, triggering questions about insider signals. This art...
SkyX’s Q1 2026 results hint at a company in transition: solid top-line momentum paired with ongoing investments. This...
Biotech earnings chants are rarely about profits for small developers. This guide explains how to read Celcuity's 202...
A surge in XRP trading on key exchanges has investors buzzing. This sign that better could point to shifting sentimen...
A new era of autonomous AI agents could turbocharge voice tech leaders. Learn how agentic will supercharge soundhound...
Owning XRP positions you in one key narrative. This guide helps you choose the best cryptocurrency already to complem...
A practical, reader-friendly guide to interpreting Xunlei's Q1 2026 earnings. Learn what to watch, how to model resul...
When a Materion director trims stake, investors should look beyond the sale. The bigger signal may lie in the company...
The AI IPO race is accelerating as OpenAI joins the fray after Anthropic. This article breaks down what the filing me...
A famed venture capital fund draws a bold parallel between SpaceX’s post-IPO trajectory and Nvidia’s 2023 surge, fram...